Merck KGaA’s Oncology Sales And Pipeline Updates Dominate Q3 Earnings
Bavencio Sees Double-Digit Growth
The German firm’s oncology franchise grew to more than €400m in the third quarter as sales of Bavencio doubled, while anticancer partnerships and pipeline updates drew interest.